Daan Dierickx

8.7k total citations · 1 hit paper
152 papers, 3.8k citations indexed

About

Daan Dierickx is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Daan Dierickx has authored 152 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Oncology, 65 papers in Pathology and Forensic Medicine and 37 papers in Hematology. Recurrent topics in Daan Dierickx's work include Lymphoma Diagnosis and Treatment (63 papers), Viral-associated cancers and disorders (47 papers) and Chronic Lymphocytic Leukemia Research (27 papers). Daan Dierickx is often cited by papers focused on Lymphoma Diagnosis and Treatment (63 papers), Viral-associated cancers and disorders (47 papers) and Chronic Lymphocytic Leukemia Research (27 papers). Daan Dierickx collaborates with scholars based in Belgium, United States and France. Daan Dierickx's co-authors include Thomas Tousseyn, Thomas M. Habermann, Iwona Włodarska, Gregor Verhoef, Julie Morscio, Olivier Gheysens, Peter Vandenberghe, Xavier Sagaert, Graciela Andreï and Robert Snoeck and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Daan Dierickx

146 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies

2015 284 citations Daan Dierickx et al. profile →

Peers

Countries citing papers authored by Daan Dierickx

Since Specialization

Citations

This map shows the geographic impact of Daan Dierickx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daan Dierickx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daan Dierickx more than expected).

Fields of papers citing papers by Daan Dierickx

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daan Dierickx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daan Dierickx. The network helps show where Daan Dierickx may publish in the future.

Co-authorship network of co-authors of Daan Dierickx

This figure shows the co-authorship network connecting the top 25 collaborators of Daan Dierickx. A scholar is included among the top collaborators of Daan Dierickx based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daan Dierickx. Daan Dierickx is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Viral Infections in HSCT Recipients with Post-Transplant Lymphoproliferative Disorder: The Role of Torque Teno Virus as a Marker of Immune Functions 2025 ·Microorganisms ·(unknown), (unknown), Robert Snoeck, Daan Dierickx, Graciela Andreï	1
2	Single center, real-world retrospective study of CAR-T cell therapy for relapsed/refractory large B-cell lymphoma beyond second line: five-year results at the University Hospitals Leuven 2024 ·Acta Clinica Belgica ·(unknown), (unknown), Bénédicte Dubois, (unknown), (unknown), Daan Dierickx, Peter Vandenberghe	2
3	Lymphoma Classifications, How to Develop a Future Unified Taxonomy 2024 ·Journal of Clinical Oncology ·Elı́as Campo, Daan Dierickx, Stefan Dirnhofer, Kieron Dunleavy, Philippe Gaulard, Robert P. Hasserjian, Elaine S. Jaffe, (unknown), Rebecca L. King, Megan S. Lim, German Ott, Miguel Á. Piris, Gilles Salles, Reiner Siebert	7
4	Genetic and immunological features of immune deficiency and dysregulation‐associated lymphoproliferations and lymphomas as a basis for classification 2024 ·Histopathology ·Daan Dierickx, Colm Keane, Yasodha Natkunam	0
5	Primary mediastinal large B‐cell lymphoma is characterized by large‐scale copy‐neutral loss of heterozygosity 2022 ·Genes Chromosomes and Cancer ·(unknown), Koen Debackere, Lukas Marcelis, Nicolas Dierckxsens, Jonas Demeulemeester, Eftychia Dimitriadou, Daan Dierickx, Pierre Lefesvre, Karen Deraedt, Carlos Graux, Lucienne Michaux, Jan Cools, Thomas Tousseyn, Joris Vermeesch, Iwona Włodarska	3
6	Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma 2022 ·Blood ·Marlies Vanden Bempt, Koen Debackere, Sofie Demeyer, (unknown), (unknown), Cristina Prieto, (unknown), Nicole Mentens, Kris Jacobs, Olga Gielen, David Nittner, Seishi Ogawa, Keisuke Kataoka, Carlos Graux, Thomas Tousseyn, Jan Cools, Daan Dierickx	12
7	[¹⁸F]FDG-PET/CT volumetric parameters can predict outcome in untreated mantle cell lymphoma 2022 ·Leukemia & lymphoma ·(unknown), Gregor Verhoef, Ann Janssens, Feng Jung Sherida H. Woei-A-Jin, Annouschka Laenen, Thomas Tousseyn, Daan Dierickx, Christophe M. Deroose	7
8	Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified 2021 ·Nature Communications ·Koen Debackere, Lukas Marcelis, Sofie Demeyer, Marlies Vanden Bempt, Nicole Mentens, Olga Gielen, Kris Jacobs, Michaël Broux, Gregor Verhoef, Lucienne Michaux, Carlos Graux, Iwona Włodarska, Philippe Gaulard, Laurence de Leval, Thomas Tousseyn, Jan Cools, Daan Dierickx	18
9	Clinical Outcomes of Solid Organ Transplant Patients with Epstein-Barr Virus-Driven (EBV +) Post-Transplant Lymphoproliferative Disorder (PTLD) Who Fail Rituximab Plus Chemotherapy: A Multinational, Retrospective Chart Review Study 2021 ·Blood ·Vikas R. Dharnidharka, (unknown), Ulrich Jaeger, (unknown), Daan Dierickx, Pengcheng Xun, (unknown), Ahmed Sawas, Natalia Sadetsky, (unknown), (unknown), Arie Barlev, Heiner Zimmermann, Ralf Ulrich Trappe	8
10	Quantitative Whole-Body Diffusion-weighted MRI after One Treatment Cycle for Aggressive Non-Hodgkin Lymphoma Is an Independent Prognostic Factor of Outcome 2021 ·Radiology Imaging Cancer ·(unknown), (unknown), Giorgio Maria Agazzi, Frederik De Keyzer, Olivier Gheysens, Oliver Bechter, Pascal Wolter, Daan Dierickx, Ann Janssens, Gregor Verhoef, Raymond Oyen, Michel Koole, Vincent Vandecaveye	2
11	The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA 2021 ·Blood Advances ·(unknown), Iwona Włodarska, (unknown), Olivier Gheysens, Luc Dehaspe, Thomas Tousseyn, Luc‐Matthieu Fornecker, Julien Lazarovici, Olivier Casasnovas, Anne‐Claire Gac, Christophe Bonnet, Kamal Bouabdallah, Christiane Copie‐Bergman, Bettina Fabiani, Daan Dierickx, Lukas Marcelis, Joris Vermeesch, Marc André, Peter Vandenberghe	18
12	Optimization of the detection of inhibitory autoantibodies against the VWF‐cleaving protease ADAMTS13 with an automated chemiluminescent ADAMTS13 activity immunoassay 2020 ·International Journal of Laboratory Hematology ·Marc Jacquemin, (unknown), (unknown), (unknown), (unknown), I. Vanlinthout, Kathelijne Peerlinck, Daan Dierickx, (unknown)	2
13	Maternal and neonatal outcomes in 80 patients diagnosed with non‐Hodgkin lymphoma during pregnancy: results from the International Network of Cancer, Infertility and Pregnancy 2020 ·British Journal of Haematology ·Charlotte Maggen, Daan Dierickx, Elyce Cardonick, Mina Mhallem Gzirí, (unknown), R.G. Shmakov, Irit Avivi, Bianca Masturzo, Johannes J. Duvekot, Petronella B. Ottevanger, (unknown), Evgeniya Polushkina, Kristel Van Calsteren, Feng Jung Sherida H. Woei-A-Jin, Frédéric Amant, (unknown)	17
14	Comparison of membrane affinity-based method with size-exclusion chromatography for isolation of exosome-like vesicles from human plasma 2018 ·Journal of Translational Medicine ·(unknown), (unknown), Jens Wouters, Pieter Vermeersch, Katarzyna Bloch, Daan Dierickx, Graciela Andreï, Robert Snoeck	323
15	Characteristics, treatment and prognosis of primary central nervous system lymphoma: a single center retrospective study 2014 ·Acta Clinica Belgica ·Daan Dierickx, (unknown), (unknown), Gregor Verhoef, Paul M. Clément, Philippe Demaerel, Thomas Tousseyn, Michel Delforge, Timothy Devos, Ann Janssens, Johan Maertens, Hélène Schoemans	1
16	Thrombotic thrombocytopenic purpura in pregnancy: a case report 2014 ·(unknown), Liesbeth Lewi, Daan Dierickx	1
17	Treatment of peripheral T-cell lymphomas: recommendations of the Belgian Hematological Society (BHS). 2013 ·Open Repository and Bibliography (University of Liège) ·(unknown), Ambro van Hoof, (unknown), Daan Dierickx, Virginie De Wilde, Fritz Offner, (unknown), Anne Sonet, (unknown), Ann Janssens, Christophe Bonnet, Bernard De Prijck, Pierre Zachée, Alain Kentos, (unknown), Éric Van Den Neste	0
18	HEMATOPOIETIC STEM CELL TRANSPLANTATION IN A PATIENT WITH WHIM SYNDROME AND PANCYTOPENIA 2012 ·Journal of Clinical Immunology ·Isabelle Meyts, Daniël Blockmans, (unknown), Xavier Bossuyt, George A. Diaz, (unknown), Daan Dierickx	1
19	Plerixafor in poor stem cell mobilizers: the belgian compassionate use program 2011 ·Lirias (KU Leuven) ·Dominik Selleslag, Daan Dierickx, (unknown), Pacific Huynh, (unknown), Stef Meers, (unknown), Ann Mertens	6
20	Rituximab therapy for immune-mediated hematological disorders: A Belgian multi-center project 2007 ·Acta Clinica Belgica ·Daan Dierickx, Ann Janssens, Gregor Verhoef, (unknown), (unknown), Alina Ferster, (unknown), (unknown), (unknown), Yves Béguin, C. Vermylen, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact